Optical Brightening Agent BA-550

We are Optical Brightening Agent BA-550 CAS:4193-55-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Optical Brightening Agent BA-550
 
Main composition
C.I.No:113
CAS No:4193-55-9
Molecular mass:960
Formula:C40H42N12O10S2Na2
Type of product:Mixture substance
 
Technical index  
Appearance:Yellow-greenish Granule
pH Value:6.0~8.0
E  Value(±20):550
Ionic character:anionic
 
Performance and Features  
1.Convenient in application, suitable for continuous addition。
2.Good fluorescent whitening performance in the pulp, surface sizing and coating processes.
 
Application Methods:
1.Convenient in application, diluted with water.
2.It can be directly added into the paper pulp, but in the course of adding, should avoid adding together with the other cationic chemicals or directly contact, mix. Adding in the pulp, the proportion based on weight of between OBA and absolute dry paper pulp is 0.03%~1.0%。
3.It can be used in cotton, dosage: 0.05-0.4% (o.w.f.); Liquor ratio: 1:10-30; Temperature: 80℃~100℃;30~60min ;
 
Packaging and Storage  
Packaging with 25kg bag, or special packaging according to customers, more than two years of stability,store at the room temperature.

Optical Brightening Agent BA-550


Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.2973-80-0 In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.AMP cíclico 3 ', 5' CAS:60-92-4 In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.(Methylthio)methylpyrazine CAS:67952-65-2 Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.

Related Products
Product Name
4-Hydrazinobenzoic acid View Details
ethyl 2-[(5-tert-butyl-1H-1,2,4-triazol-3-yl)sulfanyl]acetate View Details
3-(4-NITROPHENYL)PYRIDINE View Details
4-(Trifluoromethoxy)benzenesulfonamide manufacturer 2-Hydroxy-5-bromopyridine manufacturer Ethyl 2-bromohexanoate manufacturer (2S-cis)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one manufacturer 2-Hydroxy Phosphonoacetic Acid manufacturer